SCHEMBL9458293

SCHEMBL9458293

CCOC(=O)Cc1c(Sc2ccccc2)c2cc(F)ccc2n1Cc1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
LMNA P02545 2/20 0.56
PTGDR2 Q9Y5Y4 6/20 0.55
AKR1B1 P15121 2/20 0.55
CYP3A4 P08684 2/20 0.54
TSHR P16473 2/20 0.54
HSD17B10 Q99714 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
ALOX15 P16050 1/20 0.54
ALOX12 P18054 1/20 0.54
PPARG P37231 1/20 0.54
RECQL P46063 1/20 0.54
BLM P54132 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.53
PTGES2 Q9H7Z7 3/20 0.52
HPGD P15428 2/20 0.52
CYP2C9 P11712 2/20 0.52
KDM4E B2RXH2 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9457528 0.88 MAPT (0.53) MAPTL3MBTL1LMNAPTGDR2AKR1B1
SCHEMBL9457636 0.88 MAPT (0.61) MAPTLMNAPTGDR2AKR1B1CYP3A4
SCHEMBL9458095 0.88 MAPT (0.55) MAPTL3MBTL1LMNACYP3A4TSHR
Methane SCHEMBL9457803 0.87 MAPT (0.60) MAPTLMNAPTGDR2AKR1B1CYP3A4
SCHEMBL9457497 0.82 MAPT (0.59) MAPTPTGDR2AKR1B1CYP3A4TSHR
SCHEMBL9458259 0.81 PTGES2 (0.72) MAPTCYP3A4TSHRHSD17B10MEN1
SCHEMBL21465486 0.80 MEN1 (0.83) MAPTLMNAPTGDR2AKR1B1CYP3A4
SCHEMBL9457612 0.79 MAPT (0.42) MAPTL3MBTL1LMNACYP3A4TSHR
SCHEMBL9457791 0.77 CYP3A4 (0.58) MAPTPTGDR2AKR1B1CYP3A4TSHR
SCHEMBL23760017 0.77 MAPT (0.75) MAPTL3MBTL1LMNAPTGDR2AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5225421-A Leukotriene antagonists; cytoprotective agents MERCK FROSST CANADA, INC. (CA) 1993-07-06 US disclosed
EP-0275667-B1 3-HETERO-SUBSTITUTED-N-BENZYL-INDOLES MERCK FROSST CANADA INC. (CA) 1992-03-18 EP disclosed
US-5081138-A Antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents MERCK FROSST CANADA, INC. (CA) 1992-01-14 US disclosed
EP-0275667-A1 3-hetero-substituted-N-benzyl-indoles MERCK FROSST CANADA INC. (CA) 1988-07-27 EP disclosed